Document is current
Any future updates will be listed below
-
Authors
O’Connell, Rachel L.
Sharma, Bhupinder
El-Sharkawi, Dima
Wotherspoon, Andrew
Attygalle, Ayoma D.
MacNeill, Fiona
Khan, Aadil A.
Tasoulis, Marios-Konstantinos
- License Information
-
More Information
Article History
Received: 4 May 2023
Accepted: 19 June 2023
First Online: 15 July 2023
Disclosures
: The authors have no relevant conflicts of interest to declare. These are our disclosures of any associations, though we do not feel they are relevant to this research study. ROC: Speaker honoraria with Astra Zenica and Merck. MKT: Consultancy for BMJ Publishing Group; Speakers Bureau at Integra Life Sciences. D E-S: Honoraria from Abbvie, AstraZeneca, Beigene, Gilead, Janssen, Lily, Roche, Takeda; Conference/Travel support: Abbvie, Novartis, Roche; Advisory boards: Abbvie, ASTEX, AstraZeneca, Beigene, Janssen, Kyowa Kiirin. AA, AW, AAK, FAM and BS: no associations to declare.
